pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-2558Research ArticleЛЕКЦИИLECTIONSПереносимость физической нагрузки и качество жизни у больных хронической обструктивной болезнью легких. Влияние тиотропия бромидаPhysical tolerance and quality of life in COPD patients. Effects of tiotropium bromideБелевскийА. С.BelevskyA. S.
Москва
НИИ пульмонологии Минздрава РФRussian Federation20041908202103108112Copyright © Белевский А.С., 20212021Белевский А.С.Belevsky A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/2558
.
ReferencesGlobal initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report, updated 2003.Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report, updated 2003.Vincken W., van Noord J., Greefhorst A., et al. Improved health outcome in patients with COPD during lyr's treatment with tiotropium. Eur.Respir. J. 2002; 19: 209-216.Vincken W., van Noord J., Greefhorst A., et al. Improved health outcome in patients with COPD during lyr's treatment with tiotropium. Eur.Respir. J. 2002; 19: 209-216.Casaburi R., Mahler D., Jones P. et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 2002; 19: 217-224.Casaburi R., Mahler D., Jones P. et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 2002; 19: 217-224.Donohue J.,van Noord J., Bateman E. et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.Donohue J.,van Noord J., Bateman E. et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) improves exercise tolerance in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: 227.O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) improves exercise tolerance in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: 227.O'Donnel D., Magnussen H., Gerken F. et al. Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur. Respir. J. 2002; 20: 288s.O'Donnel D., Magnussen H., Gerken F. et al. Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur. Respir. J. 2002; 20: 288s.O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) reduces exertional dyspnea in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: A265.O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) reduces exertional dyspnea in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: A265.
The authors declare that there are no conflicts of interest present.